GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Quent Capital LLC

Quent Capital LLC decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 17.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 647 shares of the company’s stock after selling 133 shares during the quarter. Quent Capital LLC’s holdings in GE HealthCare Technologies were worth $50,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of GEHC. Jennison Associates LLC raised its holdings in shares of GE HealthCare Technologies by 49.4% during the 4th quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock worth $93,467,000 after acquiring an additional 399,961 shares during the period. South Dakota Investment Council raised its stake in GE HealthCare Technologies by 272.1% during the fourth quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock worth $7,598,000 after purchasing an additional 71,857 shares during the period. US Bancorp DE boosted its holdings in GE HealthCare Technologies by 83.4% in the 4th quarter. US Bancorp DE now owns 146,524 shares of the company’s stock valued at $11,329,000 after purchasing an additional 66,638 shares during the last quarter. Cerity Partners LLC grew its stake in shares of GE HealthCare Technologies by 27.2% in the 4th quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock valued at $3,551,000 after buying an additional 9,809 shares during the period. Finally, John G Ullman & Associates Inc. increased its holdings in shares of GE HealthCare Technologies by 93.1% during the 4th quarter. John G Ullman & Associates Inc. now owns 57,916 shares of the company’s stock worth $4,478,000 after buying an additional 27,931 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at GE HealthCare Technologies

In related news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at $5,296,510. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other GE HealthCare Technologies news, CEO Jan Makela sold 66,955 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total value of $5,459,510.70. Following the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,165,395.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the transaction, the chief technology officer now owns 67,300 shares in the company, valued at approximately $5,296,510. The disclosure for this sale can be found here. Insiders sold a total of 90,482 shares of company stock worth $7,369,137 in the last 90 days. 0.27% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a research report on Tuesday. They issued a “buy” rating and a $100.00 target price on the stock. Bank of America reduced their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target on the stock. Finally, Mizuho lowered their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Five analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $94.58.

GE HealthCare Technologies Stock Up 0.1 %

Shares of NASDAQ GEHC traded up $0.08 during mid-day trading on Wednesday, reaching $81.63. The company had a trading volume of 245,849 shares, compared to its average volume of 3,119,011. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The stock has a market cap of $37.26 billion, a P/E ratio of 23.85, a PEG ratio of 3.00 and a beta of 1.17. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.05. The firm has a 50 day simple moving average of $79.00 and a two-hundred day simple moving average of $82.61.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The business had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.92 earnings per share. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a $0.03 dividend. The ex-dividend date is Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.